Patents by Inventor Carolin Cornelius

Carolin Cornelius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusion Protein
    Publication number: 20220048955
    Abstract: The present invention relates to a fusion protein for use in the treatment and/or prevention of a hepatitis B virus infection comprising at least one hepatitis B PreS polypeptide or fragment thereof fused to at least one peptide consisting of an amino acid sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and SEQ ID No. 4.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 17, 2022
    Inventors: Rudolf Valenta, Carolin Cornelius
  • Fusion Protein
    Publication number: 20180244726
    Abstract: The present invention relates to a fusion protein for use in the treatment and/or prevention of a hepatitis B virus infection comprising at least one hepatitis B PreS polypeptide or fragment thereof fused to at least one peptide consisting of an amino acid sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and SEQ ID No. 4.
    Type: Application
    Filed: September 5, 2016
    Publication date: August 30, 2018
    Applicant: Viravaxx AG
    Inventors: Rudolf Valenta, Carolin Cornelius